Epigenetic Mechanism Links NMDA Receptor Hypofunction and Cognitive Deficits in Schizophrenia to D2 Receptors Comment

被引：4
|
作者：
Jackson, Michael F. [1 ,2 ]
机构：
[1] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada
[2] Kleysen Inst Adv Med, Neurosci Res Program, Hlth Sci Ctr, SR426,710 William Ave, Winnipeg, MB R3E 0Z3, Canada
来源：
BIOLOGICAL PSYCHIATRY | 2020年 / 87卷 / 08期
基金：
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词：
INHIBITION; DOPAMINE; COMPLEX;
D O I：
10.1016/j.biopsych.2020.01.024
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：692 / 694
页数：3
相关论文
共 50 条
  • [1] NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms
    Snyder, Melissa A.
    Gao, Wen-Jun
    SCHIZOPHRENIA RESEARCH, 2020, 217 : 60 - 70
  • [2] NMDA receptors, cognition and schizophrenia - Testing the validity of the NMDA receptor hypofunction hypothesis
    Gilmour, Gary
    Dix, Sophie
    Fellini, Laetitia
    Gastambide, Francois
    Plath, Niels
    Steckler, Thomas
    Talpos, John
    Tricklebank, Mark
    NEUROPHARMACOLOGY, 2012, 62 (03) : 1401 - 1412
  • [3] NMDA receptor hypofunction in schizophrenia and therapeutic targets for cognitive enhancement
    Coyle, JT
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 13S - 13S
  • [4] The role of D-Serine in NMDA receptor hypofunction in schizophrenia
    Coyle, Joseph T.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 234S - 234S
  • [5] THE CANNABINOID RECEPTOR 1 ASSOCIATES WITH NMDA RECEPTORS TO PRODUCE GLUTAMATERGIC HYPOFUNCTION: IMPLICATIONS FOR PSYCHOSIS AND SCHIZOPHRENIA
    Sanchez-Blazquez, P.
    Rodriguez-Munoz, M.
    Garzon, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 46 - 46
  • [6] Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia
    Gulchina, Yelena
    Xu, Song-Jun
    Snyder, Melissa A.
    Elefant, Felice
    Gao, Wen-Jun
    JOURNAL OF NEUROCHEMISTRY, 2017, 143 (03) : 320 - 333
  • [7] The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
    Sanchez-Blazquez, Pilar
    Rodriguez-Munoz, Maria
    Garzon, Javier
    FRONTIERS IN PHARMACOLOGY, 2014, 4
  • [8] Comment on "Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor" -: Reply
    Kapur, S
    Seeman, P
    BIOLOGICAL PSYCHIATRY, 2001, 50 (07) : 555 - 556
  • [9] An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia
    Darrick T Balu
    Yan Li
    Shunsuke Takagi
    Kendall Taylor Presti
    Teniel S Ramikie
    Jerri M Rook
    Carrie K Jones
    Craig W Lindsley
    P Jeffrey Conn
    Vadim Y Bolshakov
    Joseph T Coyle
    Neuropsychopharmacology, 2016, 41 : 2052 - 2061
  • [10] An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia
    Balu, Darrick T.
    Li, Yan
    Takagi, Shunsuke
    Presti, Kendall Taylor
    Ramikie, Teniel S.
    Rook, Jerri M.
    Jones, Carrie K.
    Lindsley, Craig W.
    Conn, P. Jeffrey
    Bolshakov, Vadim Y.
    Coyle, Joseph T.
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 (08) : 2052 - 2061
12345